Collectively, the results suggest that Aβ1‐42 accumulation may enhance TOM40 SUMOylation by suppressing SENP6, thereby impairing mitochondrial homeostasis through protein import failure and potentially contributing to the pathological process of AD. Here, TOMM40 is linked to Alzheimer disease.